CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 69 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2020. The put-call ratio across all filers is 57.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $527,000 | +0.2% | 28,661 | 0.0% | 0.00% | – |
| Q3 2020 | $526,000 | +17.9% | 28,661 | -3.6% | 0.00% | – |
| Q2 2020 | $446,000 | -1.3% | 29,735 | +4.2% | 0.00% | – |
| Q1 2020 | $452,000 | -2.6% | 28,526 | 0.0% | 0.00% | – |
| Q4 2019 | $464,000 | +9.4% | 28,526 | 0.0% | 0.00% | – |
| Q3 2019 | $424,000 | -10.2% | 28,526 | 0.0% | 0.00% | – |
| Q2 2019 | $472,000 | +8.0% | 28,526 | +13.2% | 0.00% | – |
| Q1 2019 | $437,000 | +0.9% | 25,203 | +2.9% | 0.00% | – |
| Q4 2018 | $433,000 | -2.7% | 24,500 | 0.0% | 0.00% | – |
| Q3 2018 | $445,000 | +5.2% | 24,500 | +13.4% | 0.00% | – |
| Q2 2018 | $423,000 | +57.8% | 21,600 | -4.9% | 0.00% | – |
| Q1 2017 | $268,000 | -10.1% | 22,709 | 0.0% | 0.00% | – |
| Q4 2016 | $298,000 | -9.7% | 22,709 | 0.0% | 0.00% | – |
| Q3 2016 | $330,000 | +20.9% | 22,709 | 0.0% | 0.00% | – |
| Q2 2016 | $273,000 | +2.2% | 22,709 | +58.7% | 0.00% | – |
| Q1 2016 | $267,000 | -13.3% | 14,309 | 0.0% | 0.00% | – |
| Q4 2015 | $308,000 | +26.7% | 14,309 | 0.0% | 0.00% | – |
| Q3 2015 | $243,000 | -54.7% | 14,309 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $537,000 | – | 14,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|